The pathophysiological basis of sensory disturbances in Parkinson's disease

Journal of the Neurological Sciences

Volumn 289, Issue 1-2, 2010, Pages 60-65

  Juri, Carlos ^a,c   Rodriguez Oroz, MariCruz ^a,b   Obeso, Jose A ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Basal ganglia; Dopamine; Non motor fluctuations; Pain; Parkinson's disease

Indexed keywords

DOPAMINE;

ARTICLE; AUTONOMIC DYSFUNCTION; BASAL GANGLION; CLINICAL STUDY; DOPAMINERGIC SYSTEM; DYSKINESIA; HUMAN; INFORMATION; INTEGRATION; NERVE CELL; NEUROMODULATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; PAIN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SENSORY SYSTEM; SOMATOSENSORY CORTEX;

ANIMALS; BASAL GANGLIA; DOPAMINE; HUMANS; PARKINSON DISEASE; SENSATION DISORDERS;

EID: 74249113945     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.08.018     Document Type: Article

References (80)

1. Shulman L.M., Taback R.L., Rabinstein A.A., and Weiner W.J. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 8 (2002) 193-197
2. Chaudhuri K.R., Healy D.G., Schapira A.H., and National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5 (2006) 235-245
3. Rahman S., Griffin H.J., Quinn N.P., and Jahanshahi M. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord 23 (2008) 1428-1434
4. Visser M., Verbaan D., van Rooden S., Marinus J., van Hilten J., and Stiggelbout A. A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value Health 12 (2008) 392-396
5. Shulman L.M., Taback R.L., Bean J., and Weiner W.J. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 16 (2001) 507-510
6. Forsaa E.B., Larsen J.P., Wentzel-Larsen T., Herlofson K., and Alves G. Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 23 (2008) 1420-1427
7. Snider S.R., Fahn S., Isgreen W.P., and Cote L.J. Primary sensory symptoms in parkinsonism. Neurology 26 (1976) 423-429
8. Artieda J., Pastor M.A., Lacruz F., and Obeso J.A. Temporal discrimination is abnormal in Parkinson's disease. Brain 115 (1992) 199-210
9. Obeso J.A., Grandas F., Vaamonde J., Luquin M.R., Artieda J., Lera G., et al. Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology 39 (1989) 11-19
10. Fahn S., and Calne D.B. Considerations in the management of parkinsonism. Neurology 28 (1978) 5-7
11. Marsden C.D., and Parkes J.D. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet 1 (1976) 292-296
12. Obeso J.A., Marin C., Rodriguez-Oroz C., Blesa J., Benitez-Temino B., Mena-Segovia J., et al. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann Neurol 64 (2009) S30-S46
13. Romanelli P., Esposito V., Schaal D.W., and Heit G. Somatotopy in the basal ganglia: experimental and clinical evidence for segregated sensorimotor channels. Brain Res Brain Res Rev 48 (2005) 112-128
14. Pasupathy A., and Miller E.K. Different time courses of learning-related activity in the prefrontal cortex and striatum. Nature 433 (2005) 873-876
15. Hikosaka O., Nakamura K., Sakai K., and Nakahara H. Central mechanisms of motor skill learning. Curr Opin Neurobiol 12 (2002) 217-222
16. Yin H.H., and Knowlton B.J. The role of the basal ganglia in habit formation. Nat Rev Neurosci 7 (2006) 464-476
17. Joel D., and Weiner I. The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry. Brain Res Brain Res Rev 23 (1997) 62-78
18. Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., Lanciego J.L., Artieda J., Gonzalo N., et al. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 23 (2000) S8-19
19. Haber S.N., Fudge J.L., and McFarland N.R. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 20 (2000) 2369-2382
20. Nambu A. A new dynamic model of the cortico-basal ganglia loop. Prog Brain Res 143 (2004) 461-466
21. Obeso J.A., Rodriguez-Oroz M.C., Javier Blesa F., and Guridi J. The globus pallidus pars externa and Parkinson's disease. Ready for prime time?. Exp Neurol 202 (2006) 1-7
22. Li C.S., Yan P., Sinha R., and Lee T.W. Subcortical processes of motor response inhibition during a stop signal task. NeuroImage 41 (2008) 1352-1363
23. Kita H., Tachibana Y., Nambu A., and Chiken S. Balance of monosynaptic excitatory and disynaptic inhibitory responses of the globus pallidus induced after stimulation of the subthalamic nucleus in the monkey. J Neurosci 25 (2005) 8611-8619
24. Jankowski J., Scheef L., Huppe C., and Boecker H. Distinct striatal regions for planning and executing novel and automated movement sequences. NeuroImage 44 (2009) 1369-1379
25. Sanchez-Gonzalez M.A., Garcia-Cabezas M.A., Rico B., and Cavada C. The primate thalamus is a key target for brain dopamine. J Neurosci 25 (2005) 6076-6083
26. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol 80 (1998) 1-27
27. Gonon F. Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J Neurosci 17 (1997) 5972-5978
28. Descarries L., Watkins K.C., Garcia S., Bosler O., and Doucet G. Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical analysis. J Comp Neurol 375 (1996) 167-186
29. Hefti F., Enz A., and Melamed E. Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs. Neuropharmacology 24 (1985) 19-23
30. Rodriguez M., Gonzalez J., Sabate M., Obeso J., and Pereda E. Firing regulation in dopaminergic cells: effect of the partial degeneration of nigrostriatal system in surviving neurons. Eur J Neurosci 18 (2003) 53-60
31. Rodriguez M., Morales I., Gonzalez-Mora J.L., Gomez I., Sabate M., Dopico J.G., et al. Different levodopa actions on the extracellular dopamine pools in the rat striatum. Synapse 61 (2007) 61-71
32. Hirsch E.C., Perier C., Orieux G., Francois C., Feger J., Yelnik J., et al. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci 23 (2000) S78-85
33. Nurmi E., Ruottinen H.M., Kaasinen V., Bergman J., Haaparanta M., Solin O., et al. Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT. Ann Neurol 47 (2000) 804-808
34. Guigoni C., Li Q., Aubert I., Dovero S., Bioulac B.H., Bloch B., et al. Involvement of sensorimotor, limbic, and associative basal ganglia domains in l-3,4-dihydroxyphenylalanine-induced dyskinesia. J Neurosci 25 (2005) 2102-2107
35. Chudler E.H., and Dong W.K. The role of the basal ganglia in nociception and pain. Pain 60 (1995) 3-38
36. Schneider J.S. Responses of striatal neurons to peripheral sensory stimulation in symptomatic MPTP-exposed cats. Brain Res 544 (1991) 297-302
37. Carelli R.M., and West M.O. Representation of the body by single neurons in the dorsolateral striatum of the awake, unrestrained rat. J Comp Neurol 309 (1991) 231-249
38. Hoover J.E., Hoffer Z.S., and Alloway K.D. Projections from primary somatosensory cortex to the neostriatum: the role of somatotopic continuity in corticostriatal convergence. J Neurophysiol 89 (2003) 1576-1587
39. Flaherty A.W., and Graybiel A.M. Corticostriatal transformations in the primate somatosensory system. Projections from physiologically mapped body-part representations. J Neurophysiol 66 (1991) 1249-1263
40. Almeida T.F., Roizenblatt S., and Tufik S. Afferent pain pathways: a neuroanatomical review. Brain Res 1000 (2004) 40-56
41. Millan M.J. The induction of pain: an integrative review. Prog Neurobiol 57 (1999) 1-164
42. Scott D.J., Heitzeg M.M., Koeppe R.A., Stohler C.S., and Zubieta J.K. Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosci 26 (2006) 10789-10795
43. Bingel U., Quante M., Knab R., Bromm B., Weiller C., and Buchel C. Subcortical structures involved in pain processing: evidence from single-trial fMRI. Pain 99 (2002) 313-321
44. Robbins T.W., and Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 6 (1996) 228-236
45. Waelti P., Dickinson A., and Schultz W. Dopamine responses comply with basic assumptions of formal learning theory. Nature 412 (2001) 43-48
46. Bingel U., Glascher J., Weiller C., and Buchel C. Somatotopic representation of nociceptive information in the putamen: an event-related fMRI study. Cereb Cortex 14 (2004) 1340-1345
47. Schultz W. Multiple dopamine functions at different time courses. Annu Rev Neurosci 30 (2007) 259-288
48. Wood P.B. Role of central dopamine in pain and analgesia. Exp Rev Neurother 8 (2008) 781-797
49. Hagelberg N., Forssell H., Rinne J.O., Scheinin H., Taiminen T., Aalto S., et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 101 (2003) 149-154
50. Wood P.B., Patterson J.C., Sunderland J.J., Tainter K.H., Glabus M.F., and Lilien D.L. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 8 (2007) 51-58
51. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 5 (2004) 385-391
52. Allen R.P., Connor J.R., Hyland K., and Earley C.J. Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis. Sleep Med 10 (2009) 123-128
53. Kernbaum S., and Hauchecorne J. Administration of levodopa for relief of herpes zoster pain. JAMA 246 (1981) 132-134
54. Dickey R.P., and Minton J.P. Levodopa relief of bone pain from breast cancer. N Engl J Med 286 (1972) 843
55. Ertas M., Sagduyu A., Arac N., Uludag B., and Ertekin C. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 75 (1998) 257-259
56. Taylor B.K., Joshi C., and Uppal H. Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 987 (2003) 135-143
57. Hagelberg N., Jaaskelainen S.K., Martikainen I.K., Mansikka H., Forssell H., Scheinin H., et al. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol 500 (2004) 187-192
58. Witjas T., Kaphan E., Azulay J.P., Blin O., Ceccaldi M., Pouget J., et al. Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 59 (2002) 408-413
59. Koller W.C. Sensory symptoms in Parkinson's disease. Neurology 34 (1984) 957-959
60. Ford B., and Pfeiffer R. Pain syndromes and disorders of sensation. In: Pfeiffer R. (Ed). Current clinical neurology. Parkinson's disease and nonmotor dysfunction (2005), Humana Press, Totowa, N.J 255-267
61. Defazio G., Berardelli A., Fabbrini G., Martino D., Fincati E., Fiaschi A., et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 65 (2008) 1191-1194
62. Negre-Pages L., Regragui W., Bouhassira D., Grandjean H., Rascol O., and DoPaMiP Study Group. Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey. Mov Disord 23 (2008) 1361-1369
63. Tinazzi M., Del Vesco C., Fincati E., Ottaviani S., Smania N., Moretto G., et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 77 (2006) 822-825
64. Quinn N.P., Koller W.C., Lang A.E., and Marsden C.D. Painful Parkinson's disease. Lancet i (1986) 1366-1369
65. Lim S.Y., Farrell M.J., Gibson S.J., Helme R.D., Lang A.E., and Evans A.H. Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?. Mov Disord 23 (2008) 1689-1695
66. Slaoui T., Mas-Gerdelat A., Ory-Magne F., Rascol O., and Brefel-Courbon C. Levodopa modifies pain thresholds in Parkinson's disease patients. Rev Neurol (Paris) 163 (2007) 66-71
67. Olanow C.W., Obeso J.A., and Stocchi F. Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications. Lancet Neurol 5 (2006) 677-687
68. Jenner P. Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev Neurosci 9 (2008) 665-677
69. Eggert K., Schrader C., Hahn M., Stamelou M., Russmann A., Dengler R., et al. Continuous jejunal levodopa infusion in patients with advanced Parkinson disease: practical aspects and outcome of motor and non-motor complications. Clin Neuropharmacol 31 (2008) 151-166
70. Isacson D., Bingefors K., Kristiansen I.S., and Nyholm D. Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion. Acta Neurol Scand 118 (2008) 379-386
71. Pascual-Sedano B., Kulisevsky J., Barbanoj M., Garcia-Sanchez C., Campolongo A., Gironell A., et al. Levodopa and executive performance in Parkinson's disease: a randomized study. JINS 14 (2008) 832-841
72. Prescott T.J., Montes Gonzalez F.M., Gurney K., Humphries M.D., and Redgrave P. A robot model of the basal ganglia: behavior and intrinsic processing. Neural Netw 19 (2006) 31-61
73. Parent M., and Parent A. The pallidofugal motor fiber system in primates. Parkinsonism Relat Disord 10 (2004) 203-211
74. Bamford N.S., Robinson S., Palmiter R.D., Joyce J.A., Moore C., and Meshul C.K. Dopamine modulates release from corticostriatal terminals. J Neurosci 24 (2004) 9541-9552
75. Nambu A. Seven problems on the basal ganglia. Curr Opin Neurobiol 18 (2008) 1-10
76. Hassler R. Striatal control of locomotion, intentional actions and of integrating and perceptive activity. J Neurol Sci 36 (1978) 187-224
77. Denny-Brown D., and Yanagisawa N. The role of the basal ganglia in the initiation of movement. Res Publ Assoc Res Nerv Ment Dis 55 (1976) 115-149
78. Ludwig J. Parkinson disease: do we need to improve treatment strategies that focus on nonmotor complications such as pain?. Nat Clin Pract Neurol 4 (2008) 478-479
79. Doucet G., Descarries L., and Garcia S. Quantification of the dopamine innervation in adult rat neostriatum. Neuroscience 19 (1986) 427-445
80. Wilson C.J. Basal ganglia. In: Shepherd G.M. (Ed). The synaptic organization of the brain (2004), Oxford University Press 361-414